Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dupilumab for sleep improvement in adults with moderate-to-severe atopic dermatitis
MOH_2019-10-07_007434Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in atopic dermatitis (AD) comparing Dupixent then open-label Dupixent with Placebo then open-label Dupixent (2 arms). Started Sep 2019; status: completed.
02
Drugs
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on MOH_2019-10-07_007434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2019-10-07_007434.